Nathalie A. Johnson
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 86
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 30
- Oncology top 1%
- CAR-T cell therapy research 30
- Cancer Immunotherapy and Biomarkers 18
- Viral-associated cancers and disorders 12
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 14
- Immunology top 2%
-
- Lung Cancer Treatments and Mutations 8
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- Randy D. GascoyneJoseph M. ConnorsLaurie H. SehnDouglas E. HorsmanSusana Ben‐NeriahKerry J. SavagePedro FarinhaPier Luigi Zinzani
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Nathalie A. Johnson
107 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Pathology and Forensic Medicine 3.0k
- Genetics 1.3k
- Oncology 2.6k
- Neurology 759
- Immunology 926
Countries citing papers authored by Nathalie A. Johnson
This map shows the geographic impact of Nathalie A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie A. Johnson more than expected).
Fields of papers citing papers by Nathalie A. Johnson
This network shows the impact of papers produced by Nathalie A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie A. Johnson. The network helps show where Nathalie A. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathalie A. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 39 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2020 | 26 | |
| 10 | 2019 | 82 | |
| 11 | 2018 | 32 | |
| 12 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 2017 | 694 |
| 13 | 2017 | 12 | |
| 14 | 2013 | 6 | |
| 15 | 2011 | 115 | |
| 16 | 2010 | 41 | |
| 17 | 2009 | 414 | |
| 18 | 2009 | 442 | |
| 19 | 2008 | 108 | |
| 20 | 2008 | 73 |
About Nathalie A. Johnson
Nathalie A. Johnson is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 114 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (86 papers), Chronic Lymphocytic Leukemia Research (30 papers), CAR-T cell therapy research (30 papers), Cancer Immunotherapy and Biomarkers (18 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.0k citations), Genetics (1.3k citations) and Oncology (2.6k citations). Nathalie A. Johnson has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn, Douglas E. Horsman, Susana Ben‐Neriah, Kerry J. Savage, Pedro Farinha, Pier Luigi Zinzani, Pauline Brice and Margaret A. Shipp. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Cancers and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.